Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy.

ADVANCE Echocardiography Substudy Investigators.; ADVANCE Collaborative Group..

J Hypertens. 2011 Jul;29(7):1439-47. doi: 10.1097/HJH.0b013e3283480fe9.

PMID:
21610514
2.

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.

Chalmers J, Joshi R, Kengne AP, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A; ADVANCE Collaborative Group..

J Hypertens Suppl. 2008 Sep;26(3):S21-7. Review.

PMID:
19363849
3.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.

Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group..

J Hypertens. 2010 Jun;28(6):1141-9.

PMID:
20486273
4.

Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.

Chalmers J, Joshi R, Kengne AP, MacMahon S.

J Hypertens Suppl. 2008 Jun;26(2):S11-5.

PMID:
18979718
5.
6.

Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.

Libhaber EN, Libhaber CD, Candy GP, Sliwa K, Kachope J, Hlatshwayo NM, Puane MO, Woodiwiss AJ, Norton GR, Essop MR, Sareli P.

Am J Hypertens. 2004 May;17(5 Pt 1):428-32.

PMID:
15110902
7.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group., MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.

PMID:
17765963
8.
9.

ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.

Perkovic V, Joshi R, Patel A, Bompoint S, Chalmers J; ADVANCE Collaborative Group..

Blood Press. 2006;15(6):340-6.

PMID:
17472024
12.

Implications of the ADVANCE study for clinical practice.

Zannad F.

J Hypertens Suppl. 2008 Sep;26(3):S29-32. Review.

PMID:
19363850
13.

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.

Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group..

Eur Heart J. 2009 May;30(9):1128-35. doi: 10.1093/eurheartj/ehp055. Epub 2009 Mar 11.

PMID:
19282274
14.

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.

Glasziou PP, Clarke P, Alexander J, Rajmokan M, Beller E, Woodward M, Chalmers J, Poulter N, Patel A.

Med J Aust. 2010 Sep 20;193(6):320-4.

PMID:
20854235
15.

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J; PROGRESS Collaborative Group..

Arch Intern Med. 2003 May 12;163(9):1069-75.

PMID:
12742805
16.

Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.

Dahlöf B, Gosse P, Guéret P, Dubourg O, de Simone G, Schmieder R, Karpov Y, García-Puig J, Matos L, De Leeuw PW, Degaute JP, Magometschnigg D; PICXEL Investigators..

J Hypertens. 2005 Nov;23(11):2063-70.

PMID:
16208150
17.
18.

Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].

Ghiadoni L.

Expert Opin Pharmacother. 2010 Jul;11(10):1647-57. doi: 10.1517/14656566.2010.491511. Erratum in: Expert Opin Pharmacother. 2010 Aug;11(11);1963.

PMID:
20518617
19.

Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.

Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME; REASON Project..

Am J Hypertens. 2004 Mar;17(3):245-51.

PMID:
15001199
20.

The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.

Waeber B, de la Sierra A, Ruilope LM.

Am J Cardiovasc Drugs. 2009;9(5):283-91. doi: 10.2165/10061600-000000000-00000. Review.

PMID:
19791837

Supplemental Content

Support Center